Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Possible manufacture of test allergens in public pharmacies for the diagnosis of type I allergies: Legal aspects.
Jost R, Kespohl S, Paulus-Tremel KE, Zimmer J, Bonertz A, Sander I, Klose T, Altin LM, Heller S, Heimke-Brinck R, Dörje F, Philippus S, Meyer M, Segebrecht S, Wessel T, Starke D, Schülke S, Raulf M, Mahler V. Jost R, et al. Among authors: dorje f. Allergol Select. 2024 Jul 22;8:251-264. doi: 10.5414/ALX02514E. eCollection 2024. Allergol Select. 2024. PMID: 39055748 Free PMC article. Review.
Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study.
Fischer S, Donhauser M, Cohnen S, Fietkau K, Vetter M, Grübel-Liehr M, Dietrich P, Rath T, Wilfer A, Sologub L, Krebs S, Dörje F, Nagore D, Meyer S, Neurath MF, Atreya R. Fischer S, et al. Among authors: dorje f. Therap Adv Gastroenterol. 2024 Nov 30;17:17562848241301887. doi: 10.1177/17562848241301887. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39619829 Free PMC article.
Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases: The Prospective, Randomized AdPhaNCED Trial.
Plechschmidt J, Fietkau K, Hepp T, Dietrich P, Fischer S, Krebs S, Neurath MF, Dörje F, Atreya R. Plechschmidt J, et al. Among authors: dorje f. Inflamm Bowel Dis. 2025 Jan 6;31(1):77-86. doi: 10.1093/ibd/izae040. Inflamm Bowel Dis. 2025. PMID: 38507608 Free PMC article. Clinical Trial.
[INTERPOLAR-prospective, interventional studies as part of the Medical Informatics Initiative to improve medication therapy safety in healthcare].
Loeffler M, Maas R, Neumann D, Scherag A; INTERPOLAR-Team. Loeffler M, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024 Jun;67(6):676-684. doi: 10.1007/s00103-024-03890-w. Epub 2024 May 15. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024. PMID: 38750238 Free PMC article. German.
A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center.
Cuba L, Dürr P, Gessner K, Häcker B, Fietkau R, Siebler J, Pavel M, Neurath MF, Berking C, Wullich B, Brückl V, Beckmann MW, Fromm MF, Dörje F. Cuba L, et al. Among authors: dorje f. JCO Oncol Pract. 2024 Sep;20(9):1219-1230. doi: 10.1200/OP.23.00694. Epub 2024 Jun 7. JCO Oncol Pract. 2024. PMID: 38848539
51 results